The RNA-binding protein FMRP facilitates the nuclear export of N6-methyladenosine–containing mRNAs
Phillip J Hsu,Hailing Shi,Allen C Zhu,Zhike Lu,Nimrod Miller,Brittany M Edens,Yongchao C Ma,Chuan He,Phillip J. Hsu,Allen C. Zhu,Brittany M. Edens,Yongchao C. Ma
DOI: https://doi.org/10.1074/jbc.AC119.010078
IF: 5.485
2019-12-27
Journal of Biological Chemistry
Abstract:N 6-Methyladenosine (m6A) is the most abundant post-transcriptional mRNA modification in eukaryotes and exerts many of its effects on gene expression through reader proteins that bind specifically to m6A-containing transcripts. Fragile X mental retardation protein (FMRP), an RNA-binding protein, has previously been shown to affect the translation of target mRNAs and trafficking of mRNA granules. Loss of function of FMRP causes fragile X syndrome, the most common form of inherited intellectual disability in humans. Using HEK293T cells, siRNA-mediated gene knockdown, cytoplasmic and nuclear fractions, RNA-Seq, and LC-MS/MS analyses, we demonstrate here that FMRP binds directly to a collection of m6A sites on mRNAs. FMRP depletion increased mRNA m6A levels in the nucleus. Moreover, the abundance of FMRP targets in the cytoplasm relative to the nucleus was decreased in Fmr1-KO mice, an effect also observed in highly methylated genes. We conclude that FMRP may affect the nuclear export of m6A-modified RNA targets.
biochemistry & molecular biology